{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04910776",
            "orgStudyIdInfo": {
                "id": "EFC14462"
            },
            "secondaryIdInfos": [
                {
                    "id": "U1111-1246-6645",
                    "type": "REGISTRY",
                    "domain": "ICTRP"
                },
                {
                    "id": "2024-513859-33",
                    "type": "REGISTRY",
                    "domain": "CTIS"
                },
                {
                    "id": "2020-004686-39",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Sanofi",
                "class": "INDUSTRY"
            },
            "briefTitle": "Clinical Study for Treatment-na\u00efve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa",
            "officialTitle": "An Open-label, Multinational, Multicenter, Intravenous Infusion Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Avalglucosidase Alfa in Treatment na\u00efve Pediatric Participants With Infantile-Onset Pompe Disease (IOPD)",
            "acronym": "Baby-COMET",
            "therapeuticArea": [
                "Other"
            ],
            "study": "clinical-study-for-treatment-iopd-babies-to-evaluate-efficacy-and-safety-of-ert-with-avalglucosidase-alfa"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-27",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-25",
            "studyFirstSubmitQcDate": "2021-06-01",
            "studyFirstPostDateStruct": {
                "date": "2021-06-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sanofi",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a single group, treatment, Phase 3, open-label study to assess efficacy, safety, pharmacokinetic (PK), pharmacodynamics (PD) of avalglucosidase alfa in treatment-na\u00efve male and female participants with IOPD.\n\nStudy details include:\n\n* Study duration: Screening - up to 4 weeks;\n* Primary Analysis Period (PAP) - 52 weeks;\n* Extended Treatment Period (ETP) - 52 weeks;\n* Extended Long term Treatment Period (ELTP) - 104 weeks; 4-week follow-up period for a total study duration - up to 4.08 years.\n* Treatment duration: Up to 4 years\n* Visit frequency: every other week and potentially every week",
            "detailedDescription": "Study duration may be variable by country, including at least completion of the PAP and ETP, and up to 4.08 years."
        },
        "conditionsModule": {
            "conditions": [
                "Glycogen Storage Disease Type II"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Avalglucosidase alfa",
                    "type": "EXPERIMENTAL",
                    "description": "Administered intravenously every 2 weeks",
                    "interventionNames": [
                        "Drug: avalglucosidase alfa"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "avalglucosidase alfa",
                    "description": "Sterile lyophilized powder intravenous (IV) infusion",
                    "armGroupLabels": [
                        "Avalglucosidase alfa"
                    ],
                    "otherNames": [
                        "GZ402666"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of participants who are alive and free of invasive ventilation at Week 52",
                    "timeFrame": "Week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of participants who are alive and free of invasive ventilation at 12 and 18 months of age",
                    "timeFrame": "at 12 and 18 months of age"
                },
                {
                    "measure": "Proportion of participants who are alive at Week 52",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Proportion of participants who are alive at 12 and 18 months of age",
                    "timeFrame": "at 12 and 18 months of age"
                },
                {
                    "measure": "Proportion of participants who are free of ventilator use (invasive and non-invasive separate and combined) at Week 52",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Proportion of participants who are free of supplemental oxygen use at Week 52",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in left ventricular mass (LVM)-Z score",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in Alberta Infant Motor Scale (AIMS) score",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in body length Z-scores",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in body weight Z-scores",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in head circumference Z-scores",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in body length percentiles",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in body weight percentiles",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in head circumference percentiles",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Change from baseline to Week 52 in urinary Hex4",
                    "timeFrame": "Week 52"
                },
                {
                    "measure": "Number of participants experiencing at least 1 treatment-emergent adverse events (TEAE), including infusion associated reactions (IAR)",
                    "timeFrame": "Week 52, Week 212"
                },
                {
                    "measure": "Number of participants with abnormalities in physical examinations",
                    "timeFrame": "Week 52, Week 208"
                },
                {
                    "measure": "Number of participants with potentially clinically significant abnormality (PCSA) in clinical laboratory results",
                    "timeFrame": "Week 52, Week 208"
                },
                {
                    "measure": "Number of participants with PCSA in vital signs measurements",
                    "timeFrame": "Week 52, Week 208"
                },
                {
                    "measure": "Number of participants with PCSA in 12-lead electrocardiogram (ECG)",
                    "timeFrame": "Week 52, Week 208"
                },
                {
                    "measure": "Incidence of treatment-emergent anti-drug antibodies (ADA)",
                    "timeFrame": "Week 52, Week 208"
                },
                {
                    "measure": "Plasma concentration of avalglucosidase alfa",
                    "timeFrame": "at Day 1, Week 12, and Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must have confirmed diagnosis of infantile-onset Pompe disease defined as: the presence of 2 lysosomal acid \u03b1-glucosidase (GAA) pathogenic variants and a documented GAA deficiency from blood, skin, or muscle tissue; or the presence of 1 GAA pathogenic variant and a documented GAA deficiency from blood, skin and muscle tissue in 2 separate samples (from either 2 different tissues or from the same tissue but at 2 different sampling dates).\n* Participants must have established cross-reactive immunological material (CRIM) status available prior to enrollment.\n* Participants must have cardiomyopathy at the time of diagnosis: ie, left ventricular mass index (LVMI) equivalent to mean age specific LVMI\n\n  * +1 standard deviation for participants diagnosed by newborn screening or sibling screening;\n  * +2 standard deviation for participants diagnosed by clinical evaluation.\n* Parents or legally authorized representative(s) must be capable of giving signed informed consent.\n\nExclusion Criteria:\n\n* Participants with symptoms of respiratory insufficiency, including any ventilation use (invasive or noninvasive) at the time of enrollment.\n* Participants with major congenital abnormality.\n* Participants with clinically significant organic disease (with the exception of symptoms relating to Pompe disease).\n* Participant received any Pompe disease specific treatment, eg enzyme-replacement gene therapy (ERT).\n* Participant who has previously been treated in any clinical trial of avalglucosidase alfa.\n* Participant not suitable for participation, whatever the reason, as judged by the Investigator, including medical or clinical conditions, or participants potentially at risk of noncompliance to study procedures.\n\nThe above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "0 Days",
            "maximumAge": "12 Months",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trial Transparency email recommended (Toll free number for US & Canada)",
                    "role": "CONTACT",
                    "phone": "800-633-1610",
                    "phoneExt": "option 6",
                    "email": "Contact-US@sanofi.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Sciences & Operations",
                    "affiliation": "Sanofi",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University Site Number : 8400006",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "Advanced Medical Genetics Site Number : 8400002",
                    "status": "RECRUITING",
                    "city": "Hawthorne",
                    "state": "New York",
                    "zip": "10532",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.10732,
                        "lon": -73.79597
                    }
                },
                {
                    "facility": "Duke University Medical Center Site Number : 8400004",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital Medical Center - PIN Site Number : 8400001",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229-3026",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Seattle Childrens Hospital and Regional Medical Center Site Number : 8400003",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98040",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Investigational Site Number : 0560001",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "zip": "3000",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560002",
                    "status": "RECRUITING",
                    "city": "Qingdao",
                    "zip": "266000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.06488,
                        "lon": 120.38042
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560001",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200127",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Investigational Site Number : 2760001",
                    "status": "RECRUITING",
                    "city": "Gie\u00dfen",
                    "zip": "35390",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.58727,
                        "lon": 8.67554
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800002",
                    "status": "RECRUITING",
                    "city": "Monza",
                    "state": "Lombardia",
                    "zip": "20900",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.58005,
                        "lon": 9.27246
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800001",
                    "status": "RECRUITING",
                    "city": "Firenze",
                    "zip": "50139",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Investigational Site Number : 5280001",
                    "status": "RECRUITING",
                    "city": "Rotterdam",
                    "zip": "3015 CN",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "Investigational Site Number : 7240001",
                    "status": "RECRUITING",
                    "city": "Esplugues de Llobregat",
                    "state": "Catalunya [Catalu\u00f1a]",
                    "zip": "08950",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.37732,
                        "lon": 2.08809
                    }
                },
                {
                    "facility": "Investigational Site Number : 1580001",
                    "status": "COMPLETED",
                    "city": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Investigational Site Number : 8260001",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "London, City Of",
                    "zip": "WC1N 3JH",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Investigational Site Number : 8260002",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M13 9WL",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006009",
                    "term": "Glycogen Storage Disease Type II"
                },
                {
                    "id": "D000006008",
                    "term": "Glycogen Storage Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002239",
                    "term": "Carbohydrate Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000020140",
                    "term": "Lysosomal Storage Diseases, Nervous System"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9114",
                    "name": "Glycogen Storage Disease",
                    "asFound": "Glycogen Storage Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9115",
                    "name": "Glycogen Storage Disease Type II",
                    "asFound": "Glycogen Storage Disease Type II",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5498",
                    "name": "Carbohydrate Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2562",
                    "name": "Glycogen Storage Disease Type 2",
                    "asFound": "Glycogen Storage Disease Type II",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}